NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine
India’s pharmaceutical pricing regulator has allowed a one-time price hike of 50 per cent for three key drugs
Read moreIndia’s pharmaceutical pricing regulator has allowed a one-time price hike of 50 per cent for three key drugs
Read moreCadila Healthcare and Bayer (South East Asia) have decided to extend the operations of their joint venture
Read moreDrug firm Zydus Cadila on Friday said it has introduced a new feature in the packaging of
Read moreDrug firm Zydus Cadila on Tuesday said it has received final approval from the US health regulator
Read moreDrugfirm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium BesylateInjection, a muscle relaxant given
Read more